SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
bluebird bio Inc.
An SI Board Since November 2013
Posts SubjectMarks Bans Symbol
163 36 0 BLUE
Emcee:  Biotech Jim Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63Matt Herper's Forbes article Gene Therapy's Big Comeback forbes.comghmm-3/26/2014
62Here is an interesting/compelling CAR-T strategy to prostate cancer using a combBiotech Jim-3/24/2014
61I don't know and press releases limit themselves to simply saying something tom pope-3/18/2014
60What is ARIA's equity stake in Bellicum?DewDiligence_on_SI-3/18/2014
59<i>Note that Bellicum Pharmaceuticals is a privately held cellular immunottom pope-3/18/2014
58Advances to CAR-T technology continue, this time with a safety switch if the cytBiotech Jim-3/18/2014
57Two pieces of news on the bluebird front... Report last evening from BLUE on 20Biotech Jim-3/6/2014
56Can the model T CARs progress from Fords to Ferraris? Here is a link to a MolBiotech Jim-3/3/2014
55OT Re Cellectis Cellectis has in the US, in New Brighton MN, most of its plant Biotech Jim-2/18/2014
54CoStim, the company just acquired by NVS for an undisclosed price, is working onDewDiligence_on_SI-2/18/2014
53Taken together with the Genfit fast track designation, it seems today is a busy tom pope-2/18/2014
52Another entrant in the CAR-T field, Cellectis, a Paris-based biotech, announces Biotech Jim-2/18/2014
51As far as a longer term payment plan which is also mentioned in the article. JJghmm-2/3/2014
50Concerning the one-and-done payment model discussed: I posted that link since IBiotech Jim-2/3/2014
49Very good article, IMO, although the focus was on QURE rather than BLUE.DewDiligence_on_SI-2/3/2014
48How much should gene therapy procedures cost? Luke Timmerman provides a view inBiotech Jim-2/3/2014
47Yes that is the case. I put part of the quote into my prior post.Biotech Jim-1/15/2014
46Did he just say, "We're keeping quiet until next year"?DewDiligence_on_SI-1/15/2014
45From Leschly's talk as per the CAR-T technology: "we're keeping quBiotech Jim-1/15/2014
44Here are the 2 goals/newsflow slides for BLUE in 2014 as presented at JPM today.Biotech Jim-1/15/2014
43Here is a link to the slide show presented at the JPM Healthcare Conference: phBiotech Jim-1/15/2014
42Just to be clear on the CCALD - by "better not hear anything", I didn&idos-1/10/2014
41Thanks! Think I'll watch and wait. Cheers, Tucktuck-1/10/2014
40They might report some initial data from the beta-thalassemia major trials lateridos-1/10/2014
39It's been noted that there were almost 17 million shares available for sale tuck-1/9/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News